Just a moment...
Generate professional replies to Show Cause Notices, assessment orders, audit objections, and other legal communications using TaxTMI's AI Drafter.
Step 1 – Issue Identification & Review
The AI analyses your query, notice, order, or uploaded documents and identifies the key issues involved.
• Review the issues identified by the AI
• Add, edit, remove, or refine issues as required
Step 2 – Draft Generation
Once you approve the issues, the AI performs issue-wise legal research and prepares a structured draft response.
• Relevant statutory provisions
• Judicial precedents and Supreme Court, High Court and other citations
• Issue-wise legal analysis
• Practical arguments and supporting content
• Professionally structured draft ready for further review. 
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether the product manufactured from streptomycin and penicillin was entitled to concessional duty as a formulation under Notification No. 8/95-C.E. dated 9-2-1995.
Analysis: The notification granted concessional duty to formulations manufactured from specified bulk drugs, and the explanation defined a formulation as a medicament processed out of or containing one or more bulk drugs, with or without therapeutic aids, subject to exclusion only where the Drugs and Cosmetics Act, 1940 did not apply. Streptomycin was among the bulk drugs specified in the notification. The authorities had denied the benefit without a clear finding showing why the product failed the explanation. The record also showed that the ratio of the product had been furnished, and there was no basis to hold that the product was outside the definition merely because the combination was not separately specified in the second schedule to the Drugs and Cosmetics Act, 1940 or because the ingredient sodium citrate was not shown to fail the test of therapeutic inertness.
Conclusion: The product was a formulation within the meaning of the notification and the concessional duty benefit was available to the assessee.
Ratio Decidendi: A medicament containing a notified bulk drug qualifies as a formulation under the exemption notification unless it is shown to fall outside the statutory definition or within the express exclusion.